HOUSE AMENDED

THE GENERAL ASSEMBLY OF PENNSYLVANIA

SENATE BILL

INTRODUCED BY VOGEL, ROBBINS, RAFFERTY, ARGALL, SOLOBAY, ALLOWAY, YAW, ORIE, BAKER, FONTANA, ERICKSON, FOLMER, PILEGGI, COSTA, TOMLINSON, WASHINGTON, FARNESE, BOSCOLA, HUGHES, CORMAN, BLAKE, BRUBAKER, SCHWANK AND MENSCH, APRIL 28, 2011

AS AMENDED ON SECOND CONSIDERATION, HOUSE OF REPRESENTATIVES, JUNE 8, 2011   

AN ACT

Amending the act of April 14, 1972 (P.L.233, No.64), entitled

"An act relating to the manufacture, sale and possession of

controlled substances, other drugs, devices and cosmetics;

conferring powers on the courts and the secretary and

Department of Health, and a newly created Pennsylvania Drug,

Device and Cosmetic Board; establishing schedules of

controlled substances; providing penalties; requiring

registration of persons engaged in the drug trade and for the

revocation or suspension of certain licenses and

registrations; and repealing an act," further providing for

Schedule I controlled substances.

The General Assembly of the Commonwealth of Pennsylvania

hereby enacts as follows:

Section 1.  Section 4(1) of the act of April 14, 1972

(P.L.233, No.64), known as The Controlled Substance, Drug,

Device and Cosmetic Act, amended November 24, 1999 (P.L.894,

No.55), is amended to read:

Section 4.  Schedules of Controlled Substances.--The

following schedules include the controlled substances listed or

to be listed by whatever official name, common or usual name,

chemical name, or trade name designated.

(1)  Schedule I--In determining that a substance comes within

this schedule, the secretary shall find: a high potential for

abuse, no currently accepted medical use in the United States,

and a lack of accepted safety for use under medical supervision.

The following controlled substances are included in this

schedule:

(i)  Any of the following opiates, including their isomers,

esters, ethers, salts, and salts of isomers, esters, and ethers,

unless specifically excepted, whenever the existence of such

isomers, esters, ethers and salts is possible within the

specific chemical designation:

 1.  Acetylmethadol.

 2.  Allylprodine.

 3.  Alphacetylmethadol.

 4.  Alphameprodine.

 5.  Alphamethadol.

 6.  Benzethidine.

 7.  Betacetylmethadol.

 8.  Betameprodine.

 9.  Betamethadol.

10.  Betaprodine.

11.  Clonitazene.

12.  Dextromoramide.

13.  Dextrorphan (except its methylether).

14.  Diampromide.

15.  Diethylthiambutene.

16.  Dimenoxadol.

17.  Dimepheptanol.

18.  Dimethylthiambutene.

19.  Dioxaphetyl butyrate.

20.  Dipipanone.

21.  Ethylmethylthiambutene.

22.  Etonitazene.

23.  Etoxeridine.

24.  Furethidine.

25.  Hydroxypethidine.

26.  Ketobemidone.

27.  Levomoramide.

28.  Levophenacylmorphan.

29.  Morpheridine.

30.  Noracymethadol.

31.  Norlevorphanol.

32.  Normethadone.

33.  Norpipanone.

34.  Phenadoxone.

35.  Phenampromide.

36.  Phenomorphan.

37.  Phenoperidine.

38.  Piritramide.

39.  Proheptazine.

40.  Properidine.

41.  Racemoramide.

42.  Trimeperidine.

(ii)  Any of the following opium derivatives, their salts,

isomers and salts of isomers, unless specifically excepted,

whenever the existence of such salts, isomers and salts of

isomers is possible within the specific chemical designation:

1.  Acetorphine.

2.  Acetyldihydrocodeine.

3.  Benzylmorphine.

4.  Codeine methylbromide.

5.  Codeine-N-Oxide.

6.  Cyprenorphine.

7.  Desomorphine.

8.  Dihydromorphine.

9.  Etorphine.

10.  Heroin.

11.  Hydromorphinol.

12.  Methyldesorphine.

13.  Methylhydromorphine.

14.  Morphine methylbromide.

15.  Morphine methylsulfonate.

16.  Morphine-N-Oxide.

17.  Myrophine.

18.  Nicocodeine.

19.  Nicomorphine.

20.  Normorphine.

21.  Pholcodine.

22.  Thebacon.

(iii)  Any material, compound, mixture, or preparation which

contains any quantity of the following hallucinogenic

substances, their salts, isomers, and salts of isomers, unless

specifically excepted, whenever the existence of such salts,

isomers, and salts of isomers is possible within the specific

chemical designation:

1.  3,4-methylenedioxy amphetamine.

2.  5-methoxy-3,4-methylenedioxy amphetamine.

3.  3,4,5-trimethoxy amphetamine.

4.  Bufotenine.

5.  Diethyltryptamine.

6.  Dimethyltryptamine.

7.  4-methyl-2,5-dimethoxyamphetamine.

8.  Ibogaine.

9.  Lysergic acid diethylamide.

10.  Mescaline.

11.  Peyote.

12.  N-ethyl-3-piperidyl benzilate.

13.  N-methyl-3-piperidyl benzilate.

14.  Psilocybin.

15.  Psilocyn.

16.  Tetrahydrocannabinols.

17.  Salvia Divinorum.

18.  Salvinorin A.

19.  Divinorin A.

20.  3,4-Methylenedioxymethcathinone (Methylone).

21.  3,4-Methyenedioxypyrovalerone (MDPV).

22.  4-Methylmethcathinone (Mephedrone).

23.  4-Methoxymethcathinone.

24.  4-Fluoromethcathinone.

25.  3-Fluoromethcathinone.

(iv)  Marihuana.

(v)  Any material, compound, mixture or preparation which

contains any quantity of the following substances, including the

salts, isomers and salts of isomers:

1.  Methaqualone.

(vi)  Gamma hydroxybutyric acid, any salt, hydroxybutyric

compound, derivative or preparation of gamma hydroxybutyric

acid, including any isomers, esters and ethers and salts of

isomers, esters and ethers of gamma hydroxybutyric acid, except

gamma-butyrolactone (GBL), whenever the existence of such

isomers, esters and salts is possible within the specific

chemical designation. For purposes of security requirements

imposed by law or regulation upon registered distributors and

registered manufacturers, this substance when manufactured,

distributed or possessed in accordance with an exemption

approved under section 505(i) of the Federal Food, Drug, and

Cosmetic Act (52 Stat. 1040, 21 U.S.C. § 301 et seq.) shall,

notwithstanding any other provision of this act, be classified

as a controlled substance in Schedule III of this section.

(vii)  Synthetic cannabinoids or any material, compound,

<--

mixture or preparation which contains any quantity of the

following substances, including the salts, isomers and salts of 

<--

their analogues, congeners, homologues, isomers, salts and salts

<--

of analogues, congeners, homologues and isomers, as follows:

1.  CP 47,497 and homologues, 2-[(1R,3S)-3-

hydroxycyclohexyl]-5-(2-methyloctan-2-yl)phenol).

2.  HU-210, [(6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-

methyloctan-2-yl)-6a,7,10, 10a-tetrahydrobenzo[c] chromen-1-

ol)].

3.  HU-211, (dexanabinol, (6aS,10aS)-9-(hydroxymethyl)-6,6-

dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-

tetrahydrobenzo[c]chromen-1-ol).

4.  JWH-018, 1-Pentyl-3-(1-naphthoyl)indole.

5.  JWH-019, 1-Hexyl-3-(1-naphthoyl)indole.

6.  JWH-073, 1-Butyl-3-(1-naphthoyl)indole.

7.  JWH-200, (1-(2-morpholin-4-ylethyl)indol-3-yl)-

naphthalen-1-ylmethanone.

8.  JWH-250, 1-pentyl-3-(2-methoxyphenylacetyl)indole.

(viii)  Psychedelic phenethylamines, their salts, their

<--

isomers and the salts of analogues, congeners, homologues,

<--

isomers, salts and the salts of analogues, congeners, homologues

and isomers as follows:

1.  2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E).

2.  2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D).

3.  2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C).

4.  2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I).

5.  2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-2).

6.  2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine (2C-

T-4).

7.  2-(2,5-Dimethoxyphenyl)ethanamine (2C-H).

8.  2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C-N).

9.  2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C-P).

* * *

Section 2.  This act shall take effect in 60 days.